Santa Cruz Biotechnology features a diverse variety of PHI Antibodies for investigating the role of PHI protein in cellular processes. PHI Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PHI protein plays a significant role in cellular signaling pathways and influences various physiological processes. Maintaining proper regulation of PHI is crucial for cellular homeostasis, while its dysregulation can contribute to multiple pathological conditions. Research has shown that PHI protein functions as a key mediator in cell-to-cell communication and metabolic regulation. Understanding PHI's molecular mechanisms and interactions provides valuable insights into cellular biology and disease development. Investigating PHI expression patterns helps reveal its distribution across different tissue types and cellular compartments. Ongoing studies continue to uncover new roles for PHI in development and disease progression. Santa Cruz Biotechnology monoclonal antibodies for PHI support researchers worldwide in advancing scientific understanding of cellular processes and potential therapeutic approaches.